共 50 条
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever
被引:5
|作者:
Bifani, Amanda Makha
[1
]
Ong, Eugenia Z.
[1
,2
]
de Alwis, Ruklanthi
[1
,2
]
机构:
[1] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore
[2] SingHlth Duke NUS, Viral Res & Expt Med Ctr VIREMiCS, Singapore, Singapore
关键词:
Yellow fever;
Epidemiology;
Vaccination;
Therapeutics;
Immunity;
Outbreak control;
SERIOUS ADVERSE EVENTS;
T-CELL RESPONSES;
17DD VACCINE;
DOUBLE-BLIND;
ADVANCED AGE;
RISK-FACTOR;
VIRUS;
IMMUNOGENICITY;
SAFETY;
IMMUNITY;
D O I:
10.1007/s40506-020-00232-7
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Purpose of Review At the turn of the nineteenth century, yellow fever (YF) was considered the most dangerous infectious disease with high case fatality. Subsequent, mass vaccination campaigns coupled with widespread elimination of the YF mosquito vector significantly decreased YF cases and reduced outbreaks to the tropical and subtropical forested regions of Africa and South America. Recent Findings However, recent (2016) large outbreaks in Angola, Democratic Republic of Congo (DRC), and South-Eastern Brazil, where previously had been demarcated as low-risk regions, have highlighted the possibility of a rapidly changing epidemiology and the potential re-emergence of yellow fever virus (YFV). Furthermore, the first-ever importation of YFV into Asia has highlighted the potential fear of YFV emerging as a global threat. In this review, we describe the changing epidemiology of YF outbreaks and highlight the use of public health policies, therapeutics, and vaccination as tools to help eliminate future YFV outbreaks.
引用
收藏
页码:349 / 360
页数:12
相关论文